Analgesic Ketamine for Battlefield Use

Agency: DEPT OF DEFENSE
State: Maryland
Type of Government: Federal
FSC Category:
  • A - Research and development
NAICS Category:
  • 541690 - Other Scientific and Technical Consulting Services
Set Aside: No Set aside used
Posted Date: Dec 16, 2025
Due Date: Jan 12, 2026
Solicitation No: HT9427-26-RFI-701
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Analgesic Ketamine for Battlefield Use
Active
Contract Opportunity
Notice ID
HT9427-26-RFI-701
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information View Changes
  • Contract Opportunity Type: Sources Sought (Updated)
  • Updated Published Date: Dec 16, 2025 11:18 am EST
  • Original Published Date: Dec 11, 2025 11:47 am EST
  • Updated Response Date: Jan 12, 2026 04:00 pm EST
  • Original Response Date: Jan 12, 2026 04:00 pm EST
  • Inactive Policy: 15 days after response date
  • Updated Inactive Date: Jan 27, 2026
  • Original Inactive Date: Jan 27, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside: No Set aside used
  • Product Service Code:
  • NAICS Code:
  • Place of Performance:
    MD 21702
    USA
Description

The purpose of this RFI is to address the OPMED WPAC PMO’s requirement for Tactical Combat Casualty Care (TCCC) solutions for acute severe pain from battlefield injuries. The OPMED WPAC PMO is conducting market research to determine the feasibility to collaborate with industry to develop, manufacturer, and receive U.S. Food and Drug Administration (FDA) approval of an analgesic ketamine product for procurement. All ketamine products for any route of administration will be considered, for example: autoinjectors, oral capsules, pumps, topical creams and patches, etc. OPMED WPAC PMO plans to release a request for proposals for the analgesic ketamine product in Fiscal Year 2026.



Please see list of attachments for other instructions.


Attachments/Links
Contact Information View Changes
Contracting Office Address
  • MEDICAL R & D CONTRACTING DIVISION 2 808 SCHREIDER STREET
  • FORT DETRICK , MD 21702
  • USA
Primary Point of Contact
Secondary Point of Contact
History

Related Document

Dec 11, 2025[Sources Sought (Original)] Analgesic Ketamine for Battlefield Use
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE)

DEPT OF DEFENSE

Due by 8/20/2029

Follow BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT

DEPT OF DEFENSE

Due by 12/31/2030

Follow Call for Solutions for Project Manager Electromagnetic Warfare & Collection (PM EW&C)

DEPT OF DEFENSE

Due by 4/22/2027

Follow Broad Agency Announcement DEVCOM C5ISR RTI Active Contract Opportunity Notice ID W56KGU23RRTID

DEPT OF DEFENSE

Due by 10/31/2027

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.